Varian Medical Systems Inc. has said it will not be sweetening its pending $1.3bn offer for Australian interventional oncology firm Sirtex Medical Ltd., even though China-based alternative asset management firm CDH Investments has formally put in a $1.4bn bid to scupper the deal.
Varian had inked an agreement in January to acquire Sirtex for Aus$28 per share, valuing the deal at Aus $1.59bn ($1.28bn). (Also see "Varian To Pay $1.3bn For Interventional...